Table 6.
Number of subjects who rated as Good, Neutral or Poor in terms of CVD risk reduction, from Day 0 to Day 28
| Type of FA | Score | OS™(EPA + DPA + DHA) | ω-3 SES | E + DSES | ω-3 RBCES | Total | Total minus E + DSES |
|---|---|---|---|---|---|---|---|
|
rTG |
Good |
26 |
26 |
9 |
27 |
88 |
79 |
|
Concentrated |
Neutral |
6 |
6 |
23 |
5 |
40 |
17 |
|
Triglyceride |
Poor |
0 |
0 |
0 |
0 |
0 |
0 |
|
EE |
Good |
19 |
23 |
10 |
16 |
68 |
58 |
|
Ethyl ester |
Neutral |
12 |
6 |
21 |
15 |
54 |
33 |
| |
Poor |
1 |
3 |
1 |
1 |
6 |
5 |
|
PL |
Good |
14 |
12 |
7 |
10 |
43 |
36 |
|
Phospho- |
Neutral |
15 |
14 |
23 |
19 |
71 |
48 |
|
lipid (krill) |
Poor |
3 |
6 |
2 |
3 |
14 |
12 |
|
TG |
Good |
18 |
12 |
7 |
9 |
46 |
39 |
|
Triglyceride |
Neutral |
10 |
15 |
25 |
21 |
71 |
46 |
| Poor | 4 | 5 | 0 | 2 | 11 | 11 |
OS™: OmegaScore™; ω-3 SES: Omega-3 Serum Equivalence Score; E + DSES: EPA + DHA Serum Equivalence Score; ω-3 RBCES: Omega-3 Red Blood Cell Equivalence Score (Omega-3 Index).